Advitech Annonces Stock Option Grants

Advitech Inc. (TSX VENTURE: AVI) announces that pursuant to the Company's stock option plan, it has granted a total of 189,000 stock options to its directors. These options have an exercise price of $0.20 per share and are valid for a period of five (5) years.

This grant of options is subject to regulatory approval.

About Advitech Inc.

Advitech is a health sciences and technology company with a mission to discover and commercialize proprietary and evidence-based natural health products. Effective and safe, these products play a role in the prevention of Immune-Mediated Inflammatory Disorders (IMID), such as psoriasis and inflammatory bowel disease. Advitech's common shares are listed on the TSX Venture Exchange under the symbol AVI. The number of common shares outstanding is 72 965 051.



The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.


Contacts:
Advitech inc.
Renaud Beauchesne, MBA
President and Chief Executive Officer
418-686-7498, ext. 228
info@advitech.com
www.advitech.com

Advitech inc.
Serge Comeau
Investor's relations
514-862-4160
s.comeau@advitech.com

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here